Fractyl Health, Inc.
GUTS
$0.64
-$0.05-6.60%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -96.91% | -85.71% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -96.91% | -85.71% |
| Cost of Revenue | -- | -- | -- | -100.00% | -90.00% |
| Gross Profit | -- | -- | -- | -93.33% | -79.59% |
| SG&A Expenses | 12.78% | 4.15% | -3.56% | -2.72% | -3.45% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.98% | -4.06% | 3.41% | 21.31% | 39.66% |
| Operating Income | 13.97% | 4.00% | -3.51% | -21.45% | -39.87% |
| Income Before Tax | -5.90% | -21.20% | -105.19% | -94.26% | -79.83% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -5.90% | -21.20% | -105.19% | -94.26% | -79.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.90% | -21.20% | -105.19% | -94.26% | -79.83% |
| EBIT | 13.97% | 4.00% | -3.51% | -21.45% | -39.87% |
| EBITDA | 14.25% | 4.25% | -3.05% | -20.86% | -39.20% |
| EPS Basic | 45.47% | 17.18% | -35.51% | 81.34% | 90.37% |
| Normalized Basic EPS | 44.75% | 17.31% | -23.62% | 77.58% | 88.14% |
| EPS Diluted | 45.47% | 17.18% | -35.51% | 81.34% | 90.37% |
| Normalized Diluted EPS | 44.75% | 17.31% | -23.62% | 77.58% | 88.14% |
| Average Basic Shares Outstanding | 168.79% | 113.65% | 74.15% | 65.22% | 137.48% |
| Average Diluted Shares Outstanding | 168.79% | 113.65% | 74.15% | 65.22% | 137.48% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |